Announcements Trials
Browse Landscape

Status

Unknown 3Completed 2

Sponsor Class

OTHER 5

Study Type

Interventional 16Observational 5

Sponsor

Cancer Type

Gynecologic 3Tumor-Agnostic 2

Conditions

Ovarian Neoplasms 3Neoplasms 2Kenny-Caffey syndrome, Type 1 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 447Surgical Procedures, Operative 164Observation 152Drug Therapy 143Radiotherapy 142Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 79Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 67Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 62Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Poly(ADP-ribose) Polymerase Inhibitors × Clear all
NCT04724031 2023-03-14

Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

Hellenic Cooperative Oncology Group

Unknown
150 enrolled
Gynecologic

Ovarian Neoplasms

NCT04774627 2021-09-23

Pancytopenia Related to PARP Inhibitors (PancytoRIB)

University Hospital, Caen

Completed
200 enrolled
Tumor-Agnostic

Neoplasms

NCT05044091 2021-09-14

HOPEI

Jiangsu Cancer Institute & Hospital

Unknown
100 enrolled
Gynecologic

Kenny-Caffey syndrome, Type 1, Ovarian Neoplasms

NCT04326023 2021-03-11

Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)

University Hospital, Caen

Completed
178 enrolled
Tumor-Agnostic

Neoplasms

NCT04582552 2021-01-20

ROMP

Jiangsu Cancer Institute & Hospital

Unknown
60 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡